As Vademecum, we celebrate AstraZeneca’s 25th anniversary. We thank them for their quality service to the healthcare sector in Turkey.

AstraZeneca is conducting 90 active clinical research studies in our country with a clinical research team of approximately 10 people.

In the last 10 years, they have invested with a real value of 160 million TL through more than 100 social impact projects. As part of their localization efforts, they have decided to localize products representing 85% of their total annual box sales volume. Since 2020, they have facilitated the production of 8 drugs in Turkey.

About the Author: Ecz. Tuna Barkın Tüküç

He graduated from Marmara University Faculty of Pharmacy in 2020 and completed a thesis-based master’s program in the Department of Pharmaceutical Technology at Marmara University’s Institute of Health Sciences in 2024. He has been working as a product manager at Vademecum Group since 2020.

Related Posts